Stability testing for applications for variations to marketing authorisation

  • Email
  • Help

This guideline applies to human and veterinary medicines.

Current effective version

Revision 2 - Adopted guideline

Reference numberEMA/CHMP/CVMP/QWP/441071/2011 Rev. 2
Effective from10/10/2014
KeywordsStability, stability testing, stability data, chemical active substance, specification, variation
DescriptionThis document provides general guidance on the stability data which have to be generated in order to support a variation to a marketing authorisation. It provides general guidance on stability testing for type IA and type IB variations and addresses the data requirements for common type II variations.

Document history

Revision 2

Current revision

Adopted guideline

Overview of comments

Draft guideline

Concept paper

In operation: 10/10/2014–present

Published: 09/04/2014

Published: 26/06/2011

Published: 03/03/2010

Revision 1Adopted guidelineIn operation: 01/12/2005–10/10/2014

Related content for human medicines 

Related content for veterinary medicines

How helpful is this page?

Average rating:

 Based on 27 ratings

Add your rating:

See all ratings
6 ratings
5 ratings
5 ratings
5 ratings
6 ratings

Tell us more